Subgen AI AB Stock Nasdaq Stockholm

SUBGEN

SE0014401121

Market Closed - Nasdaq Stockholm 12:00:00 2026-08-25 EDT			5-day change	1st Jan Change
0.0426 ^SEK	-4.91%		-19.32%	-95.59%

08-20	Subgen AI AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-20	Calendar Thursday, August 20	FW

Magnasense AB, formerly AegirBio AB is a Sweden-based medicine company focused therapeutic drug monitoring of biologic therapies in the autoimmune, oncology and neurology space. The Company offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. It aims to provide personalized treatment by tracking drugs levels in individuals. Magnasense AB combines core technologies from LifeAssays and Abreos Biosciences. LifeAssays is a diagnostics company based in Sweden, which owns the Magnia Point of Care and Point of Need reader technology. Abreos Biosciences is a California-based biotech, which is a developer of the Veritope chemistry platform for detecting levels of biologic drugs in patient samples.

Employees

Sector

More about the company

Quotes

Date	Price	Change	Volume
26-08-25	SEK 0.0426	-4.91%	37,885,674
26-08-24	SEK 0.0448	-0.44%	14,685,653
26-08-21	SEK 0.0450	-3.85%	37,848,824
26-08-20	SEK 0.0468	-10.00%	70,230,458
26-08-19	SEK 0.0520	-1.52%	18,366,587

Delayed Quote Nasdaq Stockholm

More quotes

Market Cap	84.41M 8.93M 7.65M 7.16M 6.54M 12.36M 852M 12.47M 32.9M 430M 33.53M 32.8M 1.43B	P/E 2024 *	-	P/E 2025	-2.38x
Enterprise Value	170M 17.96M 15.38M 14.41M 13.16M 24.85M 1.71B 25.08M 66.17M 864M 67.42M 65.96M 2.88B	EV / Sales 2024 *	-	EV / Sales 2025	5.24x
Free-Float	-	Yield 2024 *	-	Yield 2025	-

08-20	Subgen AI AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-20	Calendar Thursday, August 20	FW
08-11	Sweden's Subgen AI Names New CFO	MT
08-11	Subgen AI Group Announces Chief Financial Officer Changes, Effective August 17, 2026	CI
06-25	Subgen AI Files Appeal Against SEK12 Million Administrative Fine	MT
06-24	Subgen AI appeals €1.1m penalty	FW
06-24	Subgen AI AB Files Appeal Against Administrative Fine	CI
06-24	Nasdaq First North 25 reshuffles, here are the changes	FW
06-12	Subgen AI increases stake in Substrate AI as planned via directed non-cash issue	FW
06-05	Subgen AI increases stake in Substrate AI via 59.5 million SEK non-cash issue	FW
06-04	Swedish Court Upholds SEK12 Million Fine on Subgen AI Over Market Abuse Violations	MT
06-04	Administrative Court upholds administrative fine against Subgen AI	FW
06-04	The Administrative Court Upheld the Administrative Fine Imposed by the Swedish Financial Supervisory Authority Against Magnasense and Subgen AI Will Evaluate an Appeal	CI

08-20	Subgen AI Interim Report Q2 April-June 2026	AQ
08-11	Subgen AI Group Appoints Fredrik Lundqvist as Chief Financial Officer	AQ
07-29	Subgen AI announces that subsidiary Substrate AI has received initial contribution of approximately EUR 3.9 million from investors	AQ
06-30	Subgen AI’s subsidiary Substrate AI enters into issuance agreement regarding the previously communicated convertible bond financing of up to EUR 39.2 million	AQ
06-29	Spanish government authorises investment of EUR 19.2 million as part of a planned EUR 39.2 million convertible note issue in Subgen AI’s subsidiary Substrate AI	AQ

1 week	-19.32%
Current month	-5.33%
1 month	-18.39%
3 months	-60.74%
6 months	-87.47%
Current year	-95.59%

1 week	0.04	0.05
1 month	0.03	0.06
3 years	0.03	1,657
5 years	0.03	358,000

Subgen AI AB Stock Nasdaq Stockholm

Stocks

SUBGEN

SE0014401121

Valuation: Subgen AI AB

Chart: Subgen AI AB

Latest news : Subgen AI AB

Press Releases: Subgen AI AB

Quotes and Performance

Course Extremes

Managers and Directors: Subgen AI AB

Financials

Company Profile

Quotes

Manager	Title	Age	Since
Lorenzo Serratosa Gallardo CEO	Chief Executive Officer	57	2025-11-27
David Jiménez DFI	Director of Finance/CFO	-	2025-11-27
Marta Gomez ADM	Chief Administrative Officer	-	2025-11-27

Director	Title	Age	Since
Fredrik Häglund BRD	Director/Board Member	51	2020-04-30
William Vickery BRD	Director/Board Member	59	2022-05-31
Michael Schwartz BRD	Director/Board Member	56	2023-12-31

	2024	2025
Net sales	17.82M 1.89M 1.61M 1.51M 1.38M 2.61M 180M 2.63M 6.95M 90.74M 7.08M 6.93M 303M	204M 21.63M 18.52M 17.35M 15.84M 29.92M 2.06B 30.2M 79.67M 1.04B 81.18M 79.42M 3.47B
Net income	2.3M 243K 208K 195K 178K 336K 23.17M 339K 895K 11.69M 912K 892K 38.98M	-50.92M -5.39M -4.61M -4.32M -3.95M -7.45M -514M -7.52M -19.85M -259M -20.22M -19.79M -865M
Net Debt	10.61M 1.12M 962K 901K 823K 1.55M 107M 1.57M 4.14M 54.04M 4.22M 4.12M 180M	85.35M 9.03M 7.73M 7.24M 6.62M 12.5M 861M 12.61M 33.27M 435M 33.9M 33.16M 1.45B